PubRank

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

Clinical Trial ID NCT01792050

PubWeight™ 17.03‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01792050

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 2015 1.54
2 Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol 2015 1.22
3 Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 2016 1.18
4 Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy. Clin Cancer Res 2015 1.09
5 Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology 2014 1.01
6 Targeting Tregs in Malignant Brain Cancer: Overcoming IDO. Front Immunol 2013 0.99
7 IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. Trends Immunol 2016 0.96
8 A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer. Cancer Res 2015 0.86
9 Small molecule drugs with immunomodulatory effects in cancer. Hum Vaccin Immunother 2015 0.86
10 Targeting the indoleamine 2,3-dioxygenase pathway in cancer. J Immunother Cancer 2015 0.84
11 Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology 2016 0.84
12 Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential. Ther Adv Med Oncol 2016 0.81
13 Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy. Front Immunol 2014 0.80
14 Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther 2016 0.79
15 Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma. Mol Imaging 2016 0.78
16 Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery. Int J Neuropsychopharmacol 2016 0.78
17 IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells. PLoS One 2015 0.78
18 Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. Pharmacogenomics J 2015 0.77
19 1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis. Autoimmunity 2014 0.77
Next 100